Anti‑Enterocyte Antibodies
Use
Anti‑Enterocyte Antibodies is an indirect immunofluorescence assay performed at Children’s Hospital of Philadelphia and referred via Mayo Clinic Laboratories. It is intended to detect IgG, IgA, and IgM antibodies against enterocytes, serving a clinical purpose and not considered investigational. It is a CLIA‑certified high‑complexity test, not cleared or approved by FDA as the FDA determined such clearance is not necessary, and it is not orderable for New York State clients.
Special Instructions
A completed Anti‑Enterocyte Antibody (AEA) Clinical Form is required with the specimen; testing will not proceed without it. The test is batched; no PDF report is provided.
Limitations
Specimen must be serum collected in a red‑top no‑additive tube and shipped frozen. Hemolysis, lipemia, icterus, or other interference information is labeled NA. Testing is batched and turnaround time is prolonged (28–56 days), which may limit rapid clinical decision‑making.
Methodology
Immunoassay (Indirect Immunofluorescence)
Biomarkers
Result Turnaround Time
28-56 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
1 mL
Container
Red‑top no additive tube
Collection Instructions
Collect blood in a red‑top no additive tube and submit 1 mL of serum shipped frozen.